U.S. FDA approves COVID preventive Pemgarda for immunocompromised persons
Submitted by mike kraft on
The Food and Drug Administration (FDA) on March 22 granted emergency use authorization (EUA) for Invivyd's monoclonal antibody to prevent COVID-19 in immunocompromised patients, which fills a gap following the withdrawal of Evusheld in January 2023.